Operating profit before deduction of amortization: Akari Therapeutics Plc (AKTX)
Despite its dependence on external funding and the risks of failed trials, Akari Therapeutics (AKTX) is developing innovative treatments for rare immune pathologies. The company's aggregate EBITDA on the GURU.Markets chart allows for a liquidity assessment, where 0.00 serves as the current parameter value. Amidst a fierce scientific race, the business is pursuing a merger with another player to consolidate resources and ensure survival.
akaritx.com (AKTX) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Akari Therapeutics|AKTX - Long-Term Debt to Capital|Current Liabilities to Capital Akari Therapeutics plc|AKTX - Company Aggregate Debts|Debts to Book Capitalization Akari Therapeutics PLC|AKTX - Company Long-Term Debt|Company Short-Term Debts Akari Therapeutics|Quick Ratio akaritx.com
- earnings and multiples data:
AKTX - Company Net Income|Expected Net Income Akari Therapeutics|AKTX - P/E Multiple|Market Cap to Projected Earnings Akari Therapeutics plc|AKTX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Akari Therapeutics plc|AKTX - Operating profit before deduction of amortization|Earnings per share for the last four quarters Akari Therapeutics|AKTX - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months akaritx.com|AKTX - Earnings growth in current year|Expected net earnings per share growth next year Akari Therapeutics
- sales and revenue indicators:
Summary company analytics:AKTX (akaritx.com)
Investments in a high-paid staff of rare pathology researchers directly impact the operating profit of Akari Therapeutics (AKTX), as visualized by the GURU.Markets platform. This indicator aggregates daily cash flows from core operations before depreciation and taxes, allowing investors to differentiate operational lulls from periods of active business growth to assess the sustainability of the asset's fundamental value.
Competitors of Akari Therapeutics (AKTX)
Operating income before deduction of amortization argenx.com (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax Corp (ABVX) - Operating profit before deduction of amortization|ADMA Corp (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics|Operating profit before deduction of amortization IMVT|Operating profit EBITDA kiniksa.com|Profit before payment of interest, taxes and amortization Grifols Group (GRFS)|Adaptive Biotechnologies Corporation - Operating profit before amortization|Operating profit EBITDA CLDX (celldex.com)|Aurinia Pharma (AUPH) - Profit before interest, taxes and amortization|BioCryst - Operating profit EBITDA|VERA: Profit before payment of interest, taxes and amortization|DNTH: Operating profit EBITDA|Pharvaris - Income before deduction of interest, taxes and amortization|ABCL (AbCellera Bio) - Operating profit EBITDA|Operating profit EBITDA Tourmaline|Operating profit EBITDA PGEN|PHAR (pharming.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (nektar.com)|Upstream Bio (UPB) - Profit before interest, taxes and amortization|ZBIO: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Immunome Bio|GOSS: Operating profit EBITDA|KALV: Company profit before taxes, interest and amortization|SEPN (septerna.com) - Operating profit EBITDA|Pieris Pharmaceuticals, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Savara Inc. (SVRA)|Operating profit EBITDA Rigel Corp (RIGL)|Profit before payment of interest, taxes and amortization AnaptysBio Inc ANAB|astriatx.com (ATXS) - Profit before interest, taxes and amortization|enGene Bio - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization RAPT|JBIO: Operating profit EBITDA|Aclaris - Income before deduction of interest, taxes and amortization|KYTX (Kyverna Therapeutics, Inc) - Operating profit EBITDA|TLSA: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CABA (Cabaletta Bio)|VTYX - Profit before interest, taxes and amortization|Operating profit EBITDA THTX (Theratechnologies, Inc)|Company profit before taxes, interest and amortization AVTX (Avalo Therapeutics Inc.)|ELDN: Operating profit before deduction of amortization|AGEN - Operating profit EBITDA|Climb Bio Inc. (CLYM) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ZURA (Zura Bio)|Operating profit before deduction of amortization ATYR|ADAG: Income before deduction of interest, taxes and amortization|Operating profit EBITDA IMA|Operating income before deduction of amortization Shattuck Therapeutics|Operating profit EBITDA EQ (Equillium Inc)|Company profit before taxes, interest and amortization CNTB (Connect Pharma)|IMUX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization atarabio.com ATRA|IFRX: Operating profit EBITDA|XFOR (X4 Pharmaceuticals, Inc) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization adicetbio.com|CELU: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization INmune Bio Corporation (INMB)|Operating profit before deduction of amortization Barinthus Biotherapeutics Corp BRNS|Profit before payment of interest, taxes and amortization Kezar Life Sciences KZR|Income before deduction of interest, taxes and amortization SABS|Enlivex Therapeutics Ltd. - Operating profit EBITDA|QTTB - Operating profit EBITDA|GOVX (GeoVax Labs Inc) - Operating profit before deduction of amortization|Operating profit before deduction of amortization Edesa|IBIO (iBio, Inc.) - Operating profit EBITDA|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating profit before deduction of amortization Bolt Biotherapeutics, Inc. BOLT|Operating profit EBITDA HCWB (hcwbiologics.com)|Income before deduction of interest, taxes and amortization APVO|AIM ImmunoTech, Inc. - Operating profit EBITDA|ADTX (Aditxt Inc.) - Operating profit before amortization|GRI: Operating profit EBITDA|Operating profit before deduction of amortization XORTX Therapeutics|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization indaptusrx.com (INDP)|Operating profit before deduction of amortization Scinai Immunotherapeutics SCNI|Operating profit EBITDA CALI (CalciMedica Inc)|AFMD: Operating profit before amortization|ALLK - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization hookipapharma.com|IGMS: Operating profit EBITDA|ITOS: Company profit before taxes, interest and amortization|OCEA (Ocean Biomedical Corp) - Operating profit EBITDA|TCBP: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc (THRD)
